Breadcrumb Navigation

Pathophysiology of interstitial lung diseases

The pathophysiological understanding of interstitial lung diseases (ILDs) has made impressive progress over the last years leading to approved therapies and an increasing number of promising drug candidates currently tested in clinical trials. In our online seminar, an interdisplinary panel of leaders in the field will present their novel data on target identification, large scale tissue omics and image omics in the ILDs.

Standort

Online

Datum

03.02.2022

Uhrzeit

16.00 - 18.00 CEST

Program

16.oo h Welcome
Oliver Distler, Zurich, Switzerland
16.05 h Target identification and drug discovery in pulmonary fibrosis
Melanie Königshoff, Division of Pulmonary, Allergologoy and Critical Care Medicine, University of Pittsburgh, USA
16.40 h Pathophysiology of Pulmonary Fibrosis – Lessons from the Human Lung
Naftali Kaminski, Pulmonary Critical Care and Sleep Medicine, Yale School of Medicine, USA
17.15 h Application of Image-Omics in Interstitial Lung Diseases
Janine Schniering, Helmholtz Munich, German Research Center for Environmental Health, Neuherberg, D
17.50 h Summary and conclusion
Oliver Distler, Zurich, Switzerland

Participation

Start Zoom Meeting

Meeting-ID: 613 9961 2747
Kenncode: 210976

Contact

Nicole Schneider

Verantwortlicher Fachbereich

Klinik für Rheumatologie